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We aimed to study the occurrence of emphysematous lesions in symptom free smoking men of about 60 years of age
and in a matching group of never-smoking men and the relationship between pulmonary changes at high resolution
computed tomography (HRCT) and lung function tests.
Our investigation included 57 smoking and 32 never-smoking healthy men from a randomized epidemiological
study. HRCT was performed at full inspiration with a 15 mm slice thickness and a 3 cm inter-slice distance.
Evaluation was made by two radiologists unaware of smoking history. Emphysematous lesions were scored
visually. Pulmonary function tests were performed including spirometry and diusion capacity test (DLCO).
Emphysematous changes were demonstrated in 25 of 57 smokers but in only one never-smoker. DLCO/VA was
the most sensitive test for early emphysematous lesions. It also correlated with radiographical scoring.
Emphysematous lesions were evident in 44% of the healthy symptom free smokers. HRCT may reveal early
emphysematous lesions in smokers before clinical symptoms have developed.
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Chronic obstructive pulmonary disease (COPD) with
emphysema induced by smoking is a common disease in
the industrialized part of the world and causes high
morbidity with an increasing mortality rate (1). Earlier
studies (2) have stated that about 50% of all smokers will
develop chronic sputum production and chronic bronchitis.
These symptoms, however, do not predict further dete-
rioration of pulmonary function or development of
obstructive disease and emphysema (3,4). Nevertheless in
at least 15% of the smokers the condition progresses to a
degree that impairs lung function. The early symptoms and
signs linked to the development of COPD are not known.
No single inflammatory marker in the blood or locally in
the bronchial tree, and no single pulmonary function test,
has yet been identified which would make early diagnosis
possible. Often patients will deny symptoms and will seek
medical advice too late and any intervention at that time
will have a limited eect. At present much research is going
on to understand the pathology and to find early signs of
COPD with the aim of making early intervention possible.Received 16 December 1998 and accepted in revised form 22 March
1999.
Correspondence should be addressed to: Ulf Tyle´n, Department of
Radiology, Sahlgrenska University Hospital, S-413 45 Go¨teborg,
Sweden. Fax: 4631416490; E-mail: ulf.tylen@rtg.gu.se
0954-6111/00/010038+06 $35?00/0Chest radiography is widely used to detect pulmonary
lesions. This method, however, is neither sensitive nor
specific for detection of early COPD and emphysema (5).
Computed tomography (CT), and in particular high
resolution CT (HRCT), is a much more sensitive method
for detection of pulmonary disease and also provides a
much better basis for specific diagnosis (6). In a study with
HRCT on healthy volunteers Remy-Jardin et al. (7) found
significant dierences between current smokers, ex-smokers
and never-smokers with more parenchymal micronodules,
areas of ground-glass attenuation and emphysema in the
smoking group. Presence of emphysema and bronchial wall
thickening on HRCT was also associated with deterioration
of lung function. In another study HRCT detected
emphysema in patients with dyspnoea despite normal chest
radiography and normal lung function tests (8). This
suggests that HRCT may be used as a method for detection
of early COPD, in particular emphysema.
We have investigated smoking and never-smoking men,
all born in 1933, with HRCT. The men were recruited from
an epidemiological study designed for the investigation of
risk factors for cardiovascular disease (9). The aims of the
present study were 1. to investigate the incidence of
emphysematous lesions on HRCT in a group of non-
symptomatic male smokers of about 60 years of age who
had no history of lung disease in com-parison with a
matching group of men who had never smoked and 2. to
find out to what extent the changes demonstrated by
HRCT correlated to results of lung function tests.# 2000 HARCOURT PUBLISHERS LTD
Fig. 1. Low grade of emphysematous lesions limited to the
right lung.
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Our study was cross-sectional with one group of never-
smokers and one group of smokers. The purpose was to
investigate the early development of COPD induced by
smoking, in particular its eect on inflammatory and
immunological parameters. The subjects were recruited
from the randomized epidemiological study ‘Men born in
1933 in Go¨teborg’. For this study 879 men were invited 532
of whom accepted (9). This cohort included 112 smokers,
222 ex-smokers and 198 men who had never smoked. The
group of ex-smokers was not investigated further. All the
smokers were invited, as was a random sample of 60 of the
198 never-smokers.
Men having sought medical attention for any cardiopul-
monary problem including asthma (n11) or congestive
heart failure (n2) were excluded. Another 11 persons were
excluded because of various other diseases (rheumatoid,
kidney disease etc). The rest of the drop-outs were for
various reasons unavailable for the study. In all 58 smoking
and 34 never-smoking men were examined by HRCT.
Images from three subjects, one smoker and two never-
smokers were of insucient technical quality and were
therefore excluded from further analysis. The final material
therefore comprized for 89 men, 57 smokers and 32 never-
smokers. The subjects were examined in the period from
February 1994 to July 1995. Since all the men were born in
1933, they all were 61 or 62 years of age.
At the visit to our clinic the subjects first answered a
questionnaire about their health. They then had lung
function tests including spirometry and test of the diusion
capacity. These tests were followed by HRCT and a
conventional X-ray examination of the chest. The study
was approved by the Ethics Committee of Go¨teborg
University, Go¨teborg, Sweden.
HIGH RESOLUTION COMPUTED
TOMOGRAPHY
The examination was performed with a Picker PQ2000
(Picker International, Cleveland, U.S.A.). The subjects
were examined in a supine position and at full inspiration.
The entire thorax was scanned with a slice thickness of 15
mm and a 3 cm inter-slice distance. Exposure data were 130
kV and 200 mA. The images were reconstructed with the
sharp algorithm of Picker and six images were copied to
each 14''617'' film. The window width was set at 1400 HU
and the level at 7400 HU.
The images were analysed from the hard-copies by two
experienced chest radiologists independently and without
knowledge of whether the subject was a smoker or not. The
radiologists analysed each slice in each lung. The diagnosis
of emphysematous changes was based on findings of areas
of low attenuation and/or presence of stretched, narrowed
vessels. The degree of emphysema was scored as 0no
emphysema, 11–25% of the parenchymal area was
involved, 226–50% involvement, 351–75% involvement
and 4more than 75%. The scores for each slice and lung
were added and the sum divided by the number of slicesobtained. In this way a score of total lung involvement
could be calculated and the individual observer’s evalua-
tions compared. For comparison with the results of the
lung function tests the mean of the two observers’ results
was used. To evaluate the interobserver agreement in the
interpretation, a weighted kappa-analysis was used (10). All
1337 slices examined by both observers were compared.
Slices with no score dierence between the observers were
weighted 1, a score dierence of 1 was weighted 0667 and of
2, 0333. If the dierence was 3 the weight factor was set to 0.
LUNG FUNCTION METHODS
Spirometry was performed on a water sealed spirometer
and according to the Ocial statement of the European
Respiratory Society (11). Vital capacity (VC), forced
expired volume in 1 sec (FEV1) and its percentage of the
VC (FEV%) were obtained. Total lung capacity (TLC) and
residual volume (RV) was obtained using a body plethys-
mograph. The transfer factor (DLCO) and the quotient
between DLCO and the alveolar volume (VA) (DLCO/VA)
were obtained by the single breath method (12) using
standard equipment (SensorMedics 2200, SensorMedics
Corporation, The Netherlands).
The results were expressed as a percentage of the expected
(predicted) normal values. Normal values for VC, FEV1 and
FEV% were calculated according to Berglund et al. (13),
TLC and RV according to Grimby et al. (14) and DLCO
and DLCO/VA according to Salorinne (15).
Results
HIGH RESOLUTION COMPUTED
TOMOGRAPHY
Emphysematous changes were demonstrated in 25 (44%) of
the smokers but in only one (3%) of the never-smokers. The
dierence was highly significant (P50001, Fischer’s exact
test). In the never-smoking person no low attenuation areas
were demonstrated. The diagnosis was based on presence of
Fig. 2. Moderate emphysematous lesions in both lungs.
TABLE 1. Lung function in 89 never-smoking and smoking
men (percent of predicted values are given, statistical
significance tested with Mann–Whitney U-rank test)
Never-smokers
n32
Smokers
n57
Mean SD Mean SD P-value
TLC 96 12 97 13 n.s.
RV 97 21 116 32 5005
VC 94 13 88 13 n.s.
FEV1 108 16 94 17 50001
FEV% 115 8 106 11 50001
DLCO 97 13 82 13 50001
DLCO/VA 94 13 83 16 50001
For abbreviations see text.
40 U. TYLEÂ N ET AL.stretched vessels. There was a preponderance for upper lobe
location in most persons (Figs. 1 and 2). In persons in
whom emphysema was diagnosed by either of the observers
the mean values of the emphysema scores ranged from
009–163. The never-smoker had an emphysema score of
017. The scores ranged from 014–169 (median 066) for
observer A and from 000–156 (median 062) for observer
B. The dierence between the two observer’s scores plotted
against the averaged emphysema score appears in Fig. 3, a
Bland and Altman diagram (16). The weighted kappa for
all 1337 slices was calculated to be 078.
LUNG FUNCTION TESTS
The results of the lung function tests appear in Table 1. The
smokers had significantly lower FEV1, FEV%, DLCO andFig. 3. A Bland and Altman plot illustrating the
dierences between the two radiologists scoring of
emphysematous lesions in HRCT slices of 89 non-
symptomatic male subjects. There were no
emphysematous lesions according to both observers in 63
subjects.DLCO/VA and higher RV. No significant dierence
between the groups, however, was demonstrated concern-
ing TLC and VC. In an attempt to analyse whether the
emphysematous changes or other consequences of smoking
had had most influence on lung function the smokers with
emphysematous lesions were compared to those without.
The results appear in Table 2. There was a statistically
significant dierence only concerning DLCO/VA. Further-
more a significant correlation was found between the
emphysema score on HRCT and DLCO/VA (Fig. 4).
Discussion
Our study aimed at finding whether emphysematous lesions
could be detected by HRCT in smokers without clinical
symptoms. It might be anticipated that life in an urban areaTABLE 2. Lung function in 57 smoking men without and
with findings of emphysema on HRCT (Percent of
predicted values are given, statistical significance tested
with Mann–Whitney U-rank test)
No emphysema
n32
Emphysema
n25
Mean SD Mean SD P-value
TLC 94 14 101 10 n.s.
RV 110 29 122 34 n.s.
VC 87 13 90 13 n.s.
FEV1 94 17 94 18 n.s.
FEV% 109 10 103 11 n.s.
DLCO 86 15 78 15 n.s.
DLCO/VA 88 15 75 15 5001
For abbreviations see text.
Fig. 4. Correlation between the CO-uptake/alveolar
volume (transfer coecient) and the mean emphysema
score of the two observers in 26 non-symptomatic subjects
with emphysematous lesion on HRCT. The Spearman
rank correlation, Rho70568.
EMPHYSEMATOUS LESIONS AND HRCT 41with exposure for various infectious and pollutant agents
for more than 60 years should leave some traces in the lung
parenchyma. The influence of a noxious agent, in our case
tobacco smoke would best be addressed by comparison
with the appearance of the lung in an unexposed group,
matched to age, sex and place of living. As a reference for
the evaluation we therefore chose to include a group of men
from the same epidemiological study who had never
smoked. All persons, smokers and never-smokers, were
selected at random and were of the same sex and age. All
subjects were carefully interrogated and only those who
previously had not sought medical attention due to
pulmonary problems and who considered themselves
healthy without symptoms of heart and/or lung disease
were included. Smokers have been compared to never-
smokers previously. We think, however, that our study has
an advantage since little selection bias was involved and our
results are therefore representative for the population
studied. The conclusions drawn, however, are limited to
men at the age of about 60 years.
The first report on diagnosis of pulmonary emphysema
using computed tomography (CT) was published by God-
dard et al. in 1982 (17). The technique, however, was not
widely accepted until it had been refined with use of
millimetre thin slices and high spatial resolution reconstruc-
tion algorithm (HRCT) (18). In most studies patients with
symptoms of emphysema or chronic obstructive lung
disease were investigated and good correlation has been
found with lung function tests (19). The method has also
been validated in vitro by comparison with specimens from
lung surgery and post-mortem examinations and has been
demonstrated to be accurate (20). Remy-Jardin et al. (21)reported a sensitivity of 100% and a specificity of 91% with
use of targeted HRCT scans in comparison with pathology.
Other reports, however, indicate that the earliest emphyse-
matous changes may be overlooked (22). The latter
authors, however, did not use HRCT.
When sensitivity for detection of pulmonary lesions is
discussed it is important to consider the examination
technique. In our study we used high resolution reconstruc-
tion algorithm and 15 mm thick slices spaced with 3 cm
intervals. This is the usual technique for evaluation of
generalized lung parenchymal disease. Use of non-conti-
guous slices, however, implies a risk that small lesions may
be overlooked. Although emphysema may have an upper or
lower lobe preponderance depending on the type of
emphysema it still is to be considered a generalized disease
and the risk that disease is not detected because of the
examination technique may be considered small.
The main purpose of our investigation was to study the
prevalence of smoking induced parenchymal lesions by
HRCT and to compare this with a group of matched never-
smokers. The evaluation was done by two experienced
radiologists who did not have information of whether the
subject was from the group of smokers or never-smokers.
CT permits quantitation of the amount of emphysema (23).
The usual way of doing this is by visual estimation of how
much of a slice area is occupied by low attenuation
parenchyma (18). The estimation may be refined by use of
a grid (22), histogram analysis (24) or density mask (25).
The density mask technique is based on computer analysis
of how large a percentage of the pixels in a slice has HU-
values below a certain cut o level (e.g. 7950). We have
analysed our material with this technique but found that
although the technique can separate individuals with
significant emphysema from those without, it cannot
separate persons with the minor degrees present in our
material, from those without. The human eye is more
sensitive by recognizing dierences in parenchymal pattern.
We are trying to develop a computer technique for texture
analysis which might improve the possibilities. We used
visual estimation according to the method of Bergin et al.
(20). This method gives an assessment of the extent of
emphysema only. A single small emphysematous bulla gets
the same score as emphysema involving up to 25% of the
area of a slice. Since the scores of all slices were added and
divided by the number of slices the final score constitutes a
mean value for the entire lung, that is with a score of 1 there
are emphysematous lesions in less than 25% of the lung.
We did not try to dierentiate between dierent types of
emphysema. There was an upper lobe preponderance
indicating centrilobular emphysema in most individuals
but apart from the pattern of localization we do not think
that it is possible to dierentiate between dierent types of
emphysema with HRCT.
Although the method was very crude it was considered
good enough for our main purpose. Since several years we
have been using WW 1400 and WL 7400 HU for
evaluation of the lung parenchyma. A lower level setting
might have facilitated the detection of minor degrees of
emphysematous changes but may instead introduce a risk
of over-estimation of the degree. Our opinion is that
42 U. TYLEÂ N ET AL.familiarity with the reading conditions is the most
important factor and that these are kept constant. Our
inter-observer variation was low (Fig. 3) and the kappa
value shows a high rate of agreement and the scoring could
be used for comparison with lung function tests (Fig. 4).
Changes which may be induced by smoking were very
common in the group of smokers, emphysematous lesions
being present in almost half (44%) of the men. The extent
of the lesions was usually small which was to be expected
since the group included only individuals without symp-
toms. The prevalence of these changes were higher than
previously reported by Remy-Jardin et al. (7). The mean
age of their subjects, however, was only 33 years and the
smoking history therefore shorter probably explaining the
dierence.
Emphysematous lesions were also diagnosed in one
subject in the never-smoking group. The extent of lesions,
however, was small and the diagnosis was based on
presence of stretched vessels. No predisposing factor could
be demonstrated and the subject also had normal lung
function. It is therefore impossible to tell whether the
diagnosis of emphysematous lesions is correct or represents
a false positive diagnosis.
LUNG FUNCTION
Since emphysematous lesions, as demonstrated by HRCT,
correspond to morphological emphysema the relationship
between such lesions on HRCT and various lung function
indices is of interest. From this relationship, conclusions
may be drawn regarding the structural basis of various lung
function indices.
In the present study, many healthy smokers had
emphysematous lesions on HRCT and deteriorated lung
function indices. These findings are in agreement with
earlier HRCT-studies (26) and lung function studies
(27,28,29). In the analysis of the relationship between
structure and lung function indices only smokers were
included. Otherwise smoking induced changes, not obser-
vable on HRCT, may be confounding factors. In the
present analysis such hypothetical factors were assumed to
aect all smokers similarly.
DLCO/VA expresses the ability, per unit alveolar volume,
to transfer CO from alveolar gas to blood. This ability is
dependent on the area of blood/air-contact per unit of
alveolar volume. Emphysematous lesions are characterized
by a reduced amount of alveolar septa per unit volume.
Thus, both reduced DLCO/VA and emphysematous lesions
reflect decreased blood/air-contact area. DLCO/VA was
found to be significantly lower among those smokers who
had emphysematous lesions compared to those without
(Table 2). In addition, there was an inverse correlation
between the emphysema score and DLCO/VA (Fig. 4),
further supporting this relationship. This finding is in
agreement with several previous reports on patients (8, 24,
30). Gelb et al. (31) studied patients with chronic
obstructive pulmonary disease and reported a strong
correlation between emphysema score on HRCT and
DLCO/VA when FEV1 was 41 1. At lower FEV1 therewere no significant correlation indicating that airflow
obstruction may cause reduced DLCO/VA. In the present
study, FEV1 and FEV% were close to normal in most
subjects and were almost identical among smokers with and
without emphysematous lesions. Airway obstruction there-
fore appears to be an unlikely explanation for the reduction
of DLCO/VA. Figure 4 also indicates low DLCO/VA in
subjects with minimal emphysema. This is almost certainly
an expression of the expected methodological variation.
The coecient of variation of the never-smokers was
14% (Table 2) which is identical to the reference material
(15). A somewhat higher coecient of variation would be
expected among smokers, thus explaining the scatter in
Fig. 4.
TLC, RV, FEV1 or FEV% were highly significantly
dierent between never-smokers and smokers in accor-
dance with previous observations (30,31). These variables
were, however, not significantly dierent between smokers
with and without emphysematous lesions. Thus emphysema
appears not to be the main cause of these eects on lung
volumes and forced expiratory flow. Other smoking
induced eects on the lungs may be responsible, for
example airway obstruction caused by inflammation.
It ought to be remembered that the present material
consists of individuals with very mild radiological and
functional defects. Relationships may exist in a material
with more severe disease. On the other hand, this material is
unique in as far as all subjects are of the same age and the
same gender, reducing these sources of variability.
CONCLUSIONS
Our study has shown that 1. smoking induced pulmonary
lesions, that is emphysematous lesions, are common in non-
symptomatic smoking men of about 60 years of age and
born in Go¨teborg compared to a matched group of healthy
never-smokers and that 2. smoking induced deterioration of
lung function is mainly due to other factors than lesions
identified on HRCT or that it is possible by HRCT to
demonstrate morphological changes in a stage before
symptoms develop. The structural basis for the emphyse-
matous lesions identified on HRCT may, however, also be
the basis for deterioration of DLCO/VA.
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